Open access · US-GOV
via ClinicalTrials.gov Clinical trial
Cardiovascular Comorbidities, Inflammation, Aging and Bronchiectasis
Authors not listed
Centre Hospitalier Intercommunal Creteil · 2016
Abstract
Bronchiectasis have multiple etiologies but share a similar bronchial injury associated with inflammation, which leads to a progressive lung deterioration. This disease is responsible for a frequent access to care with an exacerbation rate of 1.8 per year with a high risk of hospitalization. Natural history is marked by recurrent infectious diseases which are the main prognosis factor. This disease is associated with an inflammation rate in the lung as well as in the blood. Up to now, no study has been described comorbidities associated with this chronic disease but our hypothesis is that cardiovascular diseases will be more frequent in these patients. In fact systemic inflammation driven by bronchial infections may increase frequency of cardiovascular diseases.
The investigators decide to conduct a monocentric observational study to define the prevalence and characterization of cardiovascular comorbidities as well as markers of accelerated aging. We would like to test the hypothesis that cardiovascular comorbidities are frequent in bronchiectasis and may be associated with markers of inflammation and aging.
Phenotype of the lung disease will include: spirometry, plethysmography, DLCO measurement according to the ATS/ERS guideline. 6M walking test and echocardiography will be also performed.
Frequency of comorbidities will be calculated with data from questionnaire as well as standardized explorations.
Aging related manifestations will be measured: arterial stiffness using aortic pulse wave velocity, bone mineral density using dual energy X-ray absorptiometry. Appendicular skeletal muscle mass and grip test were also performed.
Blood test were also performed to measure inflammatory markers, cytokines and length of telomere(definition) in circulating leucocytes.
◌ CITATION ONLY
Full text is not openly licensed for redistribution here. Read it at the source:
Provenance
- Source
- ClinicalTrials.gov
- Canonical
- link ↗
- Fetched
- 2026-10-09 MST
Cite this
APA
Anonymous. (2016). Cardiovascular Comorbidities, Inflammation, Aging and Bronchiectasis. <em>Centre Hospitalier Intercommunal Creteil</em>. https://clinicaltrials.gov/study/NCT02804971
Vancouver
Anonymous. Cardiovascular Comorbidities, Inflammation, Aging and Bronchiectasis. Centre Hospitalier Intercommunal Creteil. 2016.
BibTeX
@misc{anon2016Cardio,
title = {Cardiovascular Comorbidities, Inflammation, Aging and Bronchiectasis},
author = {Anonymous},
journal = {Centre Hospitalier Intercommunal Creteil},
year = {2016},
}
Research neighborhood
References, citing works, and semantically nearest findings. Click a node to open it.
Related findings
Aging Cell 2007
Open access · OA
Telomere length and cardiovascular risk factors in a middle‐aged population free of overt cardiovascular disease
PLoS ONE 2015
Open access · CC-BY
Association of Insulin Resistance, Arterial Stiffness and Telomere Length in Adults Free of Cardiovascular Diseases
Genes 2016
Open access · CC-BY
Telomeres and Telomerase in Cardiovascular Diseases
Pulse 2014
Open access · OA
Gender Difference in Arterial Stiffness in a Multicenter Cross-Sectional Study: The Korean Arterial Aging Study (KAAS)
American Journal of Respiratory and Critical Care Medicine 2007
Citation only
Arterial Stiffness and Osteoporosis in Chronic Obstructive Pulmonary Disease
Tzu Chi Medical Journal 2020
Open access · CC-BY